NCT02625259View on ClinicalTrials.gov

A Study to Evaluate the Relative Bioavailability, Effect of Food, and Gastric Potential Hydrogen (pH) Modification on the Pharmacokinetics of TAK-117 (MLN1117) in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

January 8, 2016

Primary Completion Date

May 16, 2016

Study Completion Date

July 22, 2016

Conditions
Neoplasm, Advanced or Metastatic
Interventions
DRUG

TAK-117

TAK-117 capsules

DRUG

Lansoprazole

Lansoprazole capsules

DRUG

TAK-117

TAK-117 tablets

Sponsors
All Listed Sponsors
lead

Millennium Pharmaceuticals, Inc.

INDUSTRY

NCT02625259 - A Study to Evaluate the Relative Bioavailability, Effect of Food, and Gastric Potential Hydrogen (pH) Modification on the Pharmacokinetics of TAK-117 (MLN1117) in Healthy Participants | Biotech Hunter | Biotech Hunter